Rosanna Dono

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Functional targeting of Glypican-4 by a conformation-specific single-domain antibody.

Functional targeting of Glypican-4 by a conformation-specific single-domain antibody.

Journal: Biomaterials

Published: May 11, 2025

Substrate stiffness alters layer architecture and biophysics of human induced pluripotent stem cells to modulate their differentiation potential.

Substrate stiffness alters layer architecture and biophysics of human induced pluripotent stem cells to modulate their differentiation potential.

Journal: iScience

Published: February 01, 2024

Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson's disease.

Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson's disease.

Journal: Scientific reports

Published: September 05, 2023

MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities.

MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities.

Journal: Cell death & disease

Published: June 23, 2022

Epithelial disruption drives mesendoderm differentiation in human pluripotent stem cells by enabling TGF-β protein sensing.

Epithelial disruption drives mesendoderm differentiation in human pluripotent stem cells by enabling TGF-β protein sensing.

Journal: Nature communications

Published: November 11, 2021

Enhanced differentiation of human induced pluripotent stem cells toward the midbrain dopaminergic neuron lineage through GLYPICAN-4 downregulation.

Enhanced differentiation of human induced pluripotent stem cells toward the midbrain dopaminergic neuron lineage through GLYPICAN-4 downregulation.

Journal: Stem cells translational medicine

Published: April 25, 2020

ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma.

ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma.

Journal: Journal of hepatology

Published: April 10, 2020

Large-Scale Virtual Screening Against the MET Kinase Domain Identifies a New Putative Inhibitor Type.

Large-Scale Virtual Screening Against the MET Kinase Domain Identifies a New Putative Inhibitor Type.

Journal: Molecules (Basel, Switzerland)

Published: January 27, 2020

Tracking Dynamics of Spontaneous Tumors in Mice Using Photon-Counting Computed Tomography.

Tracking Dynamics of Spontaneous Tumors in Mice Using Photon-Counting Computed Tomography.

Journal: iScience

Published: July 26, 2019

Publisher Correction: Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer.

Publisher Correction: Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer.

Journal: Nature communications

Published: September 27, 2018

Evaluating the landscape of gene cooperativity with receptor tyrosine kinases in liver tumorigenesis using transposon-mediated mutagenesis.

Evaluating the landscape of gene cooperativity with receptor tyrosine kinases in liver tumorigenesis using transposon-mediated mutagenesis.

Journal: Journal of hepatology

Published: August 10, 2018

Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer.

Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer.

Journal: Nature communications

Published: November 01, 2017

Showing 1-12 of 20

Last Updated: 09/26/2026